177 related articles for article (PubMed ID: 27876303)
21. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
[TBL] [Abstract][Full Text] [Related]
22. Mohs versus surgical excision in nonmelanoma skin cancers: does location matter?
Pereira CT; Kruger EA; Sayer G; Kim J; Hu J; Miller TA; Rudkin GH
Ann Plast Surg; 2013 Apr; 70(4):432-4. PubMed ID: 23486132
[TBL] [Abstract][Full Text] [Related]
23. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
Schell AE; Russell MA; Park SS
JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
[TBL] [Abstract][Full Text] [Related]
24. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
25. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.
Miñano Medrano R; López Estebaranz JL; Sanmartin-Jiménez O; Garcés JR; Rodríguez-Prieto MA; Vilarrasa-Rull E; de Eusebio-Murillo E; Escutia-Muñoz B; Flórez-Menéndez Á; Artola-Igarza JL; Alfaro-Rubio A; Redondo P; Delgado-Jiménez Y; Sánchez-Schmidt JM; Allende-Markixana I; Alonso-Pacheco ML; García-Bracamonte B; de la Cueva-Dobao P; Navarro-Tejedor R; Ciudad-Blanco C; Carnero-González L; Vázquez-Veiga H; Cano-Martínez N; Ruiz-Salas V; Sánchez-Sambucety P; Botella-Estrada R; González-Sixto B; Martorell-Calatayud A; Gil P; Morales-Gordillo V; Toll-Abelló A; Ocerin-Guerra I; Mayor-Arenal M; Suárez-Fernández R; Sainz-Gaspar L; Descalzo MA; García-Doval I;
Actas Dermosifiliogr; 2022 May; 113(5):451-458. PubMed ID: 35431059
[TBL] [Abstract][Full Text] [Related]
26. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
27. Utilization of Topographical Mohs Micrographic Surgery Maps for Rapid Review of Clinicopathologic Characteristics of Nonmelanoma Skin Cancers of the Ear.
Tolkachjov SN
Dermatol Surg; 2018 Jan; 44(1):25-30. PubMed ID: 28858932
[TBL] [Abstract][Full Text] [Related]
28. Clinical and Financial Implications of Positive Margins After Nonmelanoma Skin Cancer Resection: A Longitudinal Evaluation.
Ranganath B; Teixeira RM; Patel T; Garza R; Murphy RX
Ann Plast Surg; 2021 Jul; 87(1):80-84. PubMed ID: 33009148
[TBL] [Abstract][Full Text] [Related]
29. Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery.
Pomerantz R; Zell D; McKenzie G; Siegel DM
Case Rep Dermatol; 2011 Sep; 3(3):212-8. PubMed ID: 22110434
[TBL] [Abstract][Full Text] [Related]
30. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative Frozen Section Analysis for the Excision of Nonmelanoma Skin Cancer: A Single-Center Experience.
Bilden TT; Benedict KC; Lamb PW; McMullin J
Am Surg; 2019 Dec; 85(12):1397-1401. PubMed ID: 31908225
[TBL] [Abstract][Full Text] [Related]
32. Mohs Micrographic Surgery: Past, Present, and Future.
Cohen DK; Goldberg DJ
Dermatol Surg; 2019 Mar; 45(3):329-339. PubMed ID: 30608296
[TBL] [Abstract][Full Text] [Related]
33. Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer.
Shelton ME; Adamson AS
Dermatol Clin; 2019 Oct; 37(4):425-433. PubMed ID: 31466583
[TBL] [Abstract][Full Text] [Related]
34. Peri-operative delineation of non-melanoma skin cancer margins in vivo with handheld reflectance confocal microscopy and video-mosaicking.
Flores E; Yélamos O; Cordova M; Kose K; Phillips W; Lee EH; Rossi A; Nehal K; Rajadhyaksha M
J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1084-1091. PubMed ID: 30811707
[TBL] [Abstract][Full Text] [Related]
35. Eighteen years of experience in Mohs micrographic surgery and conventional excision for nonmelanoma skin cancer treated by a single facial plastic surgeon and pathologist.
van der Eerden PA; Prins ME; Lohuis PJ; Balm FA; Vuyk HD
Laryngoscope; 2010 Dec; 120(12):2378-84. PubMed ID: 21046543
[TBL] [Abstract][Full Text] [Related]
36. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
Cumberland L; Dana A; Liegeois N
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
[TBL] [Abstract][Full Text] [Related]
37. Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer.
Rogers EM; Connolly KL; Nehal KS; Dusza SW; Rossi AM; Lee E
J Am Acad Dermatol; 2018 Jun; 78(6):1119-1124. PubMed ID: 29288096
[TBL] [Abstract][Full Text] [Related]
38. Post-Mohs micrographic surgical margin tissue evaluation with permanent histopathologic sections.
Campbell RM; Barrall D; Wilkel C; Robinson-Bostom L; Dufresne RG
Dermatol Surg; 2005 Jun; 31(6):655-8; discussion 658. PubMed ID: 15996415
[TBL] [Abstract][Full Text] [Related]
39. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
40. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
